Bausch Health Companies Inc.
A Canadian healthcare company behind some of the world's best-known eye and skin products, Bausch Health makes contact lenses, dry-eye treatments, and the Thermage skin-tightening device, while its Salix arm sells the gut medicine Xifaxan. Its roots trace to an 1853 Rochester optical shop founded by John Jacob Bausch, who borrowed money from friend Henry Lomb to get the business going. The company began as ICN Pharmaceuticals in 1959 and later renamed itself after the famous lens maker it acquired — the firm that brought America its first mass-produced soft contact lenses in 1971.
Granted 220.9K · Bought 44.32M
Bought 2.50M
Granted 3.11M
Granted 791.5K
Granted 678.3K · Sold 60.1K
Granted 440.6K
Granted 146.0K
Granted 135.6K
Granted 135.6K
Granted 89.7K
Granted 10.6K
Granted 123.1K
Granted 138.2K
Granted 89.7K
Granted 135.6K
Granted 135.6K · Sold 40.4K
Granted 90.2K
Granted 76.0K
Granted 73.2K
Granted 45.9K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Paulson JohnDirector · 21 transactions | +183.1% | 73.67M | 220.9K | 44.32M | — |
| Paulson & Co. Inc.10% owner · 1 transaction | — | 73.26M | — | 2.50M | — |
| Appio ThomasChief Executive Officer, Director · 13 transactions | +252% | 3.45M | 3.11M | — | — |
| Charhon Jean-JacquesEVP, CFO · 5 transactions | — | 706.5K | 791.5K | — | — |
| Carson SeanaEVP, General Counsel · 34 transactions | +39.1% | 616.8K | 678.3K | — | 60.1K |
| Vadaketh Tom GeorgeEVP, Chief Financial Officer · 1 transaction | -7.2% | 564.9Kas of Sep 2023 | — | — | — |
| Lenar Aimee J.EVP, US Pharma · 6 transactions | — | 400.3K | 440.6K | — | — |
| Wechsler Amy BDirector · 14 transactions | +87.1% | 313.6K | 146.0K | — | — |
| Power Robert NDirector · 3 transactions | +82.2% | 300.6K | 135.6K | — | — |
| Kavanagh Sarah BDirector · 3 transactions | +92.4% | 282.2K | 135.6K | — | — |
| Miller Steven DDirector · 2 transactions | +60% | 239.2Kas of May 2025 | 89.7K | — | — |
| Robertson Russel CDirector · 3 transactions | +5% | 225.3Kas of Mar 2024 | 10.6K | — | — |
| Icahn BrettDirector · 10 transactions | +126.6% | 220.3Kas of Jun 2025 | 123.1K | — | — |
| Barresi John SSVP, Controller & CAO · 8 transactions | +162.8% | 197.4Kas of Feb 2025 | 138.2K | — | — |
| Mulligan RichardDirector · 2 transactions | +136.1% | 155.6Kas of May 2025 | 89.7K | — | — |
| Garcia Christian ADirector · 3 transactions | — | 135.6K | 135.6K | — | — |
| Lee Frank D.Director · 5 transactions | — | 95.2K | 135.6K | — | 40.4K |
| Leung SandraDirector · 5 transactions | — | 90.2K | 90.2K | — | — |
| Goettler MichaelDirector · 2 transactions | — | 76.0K | 76.0K | — | — |
| Lee Steven HyosigSVP, Controller & CAO · 2 transactions | — | 73.2K | 73.2K | — | — |
| Roberts EiryDirector · 1 transaction | — | 45.9K | 45.9K | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last 3 years: +46.72M shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.